Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lisa Van den Bosch"'
Autor:
Erik W Korevaar, Roel J H M Steenbakkers, Arjen van der Schaaf, Johannes A. Langendijk, Stefan Both, Hans Paul van der Laan, Lisa Van den Bosch
Publikováno v:
Radiotherapy and Oncology, 162, 85-90. ELSEVIER IRELAND LTD
PURPOSE: To evaluate the feasibility of semi-automatic Quality of Life (QOL)-weighted normal tissue complication probability (NTCP)-guided VMAT treatment plan optimisation in head and neck cancer (HNC) and compare predicted QOL to that obtained with
Autor:
Yan, Li, N M, Sijtsema, S P M, de Vette, Roel J H M, Steenbakkers, Fan, Zhang, Walter, Noordzij, Lisa, Van den Bosch, J A, Langendijk, L V, van Dijk
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
Previously, PET image biomarkers (PET-IBMs) - the 90thpercentile standardized uptake value (P90-SUV) and the Mean SUV (Mean-SUV) ofthe contralateral parotid gland (cPG) - were identified as predictors for late-xerostomiafollowing head and neck cancer
Autor:
Arjen van der Schaaf, Ewoud Schuit, Hans Paul van der Laan, Roel J H M Steenbakkers, Lisa Van den Bosch, Johannes A. Langendijk
Publikováno v:
Radiotherapy and Oncology, 160, 47-53. ELSEVIER IRELAND LTD
PURPOSE: The aim of this study is to establish the relative impact of physician-rated toxicities and patient-rated symptoms in head and neck cancer (HNC) on quality of life (QOL) and to weigh the various toxicities and symptoms during treatment plan
Autor:
Karel G.M. Moons, Johanna G M van den Hoek, Lisa Van den Bosch, Oda B. Wijers, Johannes A. Langendijk, Johannes B. Reitsma, Roel J H M Steenbakkers, Hans Paul van der Laan, Ewoud Schuit, Arjen van der Schaaf, Frank J. P. Hoebers
Publikováno v:
Radiotherapy and Oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and Oncology, 157, 147-154. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and Oncology, 157, 147-154. ELSEVIER IRELAND LTD
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiation treatment optimisation, minimising toxicity burden, in head and neck cancer (HNC) patients. We aimed to develop and externally validate NTCP model
Autor:
Hans Paul van der Laan, Lisa Van den Bosch, Hendrik P. Bijl, M. Dieters, Roel J H M Steenbakkers, Johannes A. Langendijk, Johanna G M van den Hoek, Evert S M van Aken
Publikováno v:
Radiotherapy and Oncology, 157, 182-187. ELSEVIER IRELAND LTD
Background and purpose: Radiotherapy in the head and neck area may cause vascular damage to the carotid arteries, increasing the risk of anterior circulation ischaemic cerebrovascular events (ICVEs). However, limited data exists on the relationship b
Autor:
Yan Li, Nanna Maria Sijtsema, Suzanne Petronella Maria de Vette, Roel Johannes Henricus Marinus Steenbakkers, Fan Zhang, Walter Noordzij, Lisa Van den Bosch, Johannes Albertus Langendijk, Lisanne Vania van Dijk
Publikováno v:
Radiotherapy and Oncology, 180:109458. ELSEVIER IRELAND LTD
Background and purpose: Previously, PET image biomarkers (PET-IBMs) – the 90th percentile standardized uptake value (P90-SUV) and the Mean SUV (Mean-SUV) of the contralateral parotid gland (cPG) – were identified as predictors for late-xerostomia
Autor:
Roel J H M Steenbakkers, Arjen van der Schaaf, Johannes A. Langendijk, Hans Paul van der Laan, Johannes B. Reitsma, Lisa Van den Bosch, Frank J. P. Hoebers, Karel G.M. Moons, Ewoud Schuit
Publikováno v:
Radiotherapy and Oncology, 148, 151-156. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 148, 151-156. Elsevier Ireland Ltd
Radiotherapy and Oncology, 148, 151-156. Elsevier Ireland Ltd
Normal Tissue Complication Probability (NTCP) models can be used for treatment plan optimisation and patient selection for emerging treatment techniques. We discuss and suggest methodological approaches to address key challenges in NTCP model develop
Autor:
Roel J H M Steenbakkers, Lisa Van den Bosch, Stefan Both, Johannes A. Langendijk, Charlotte L. Brouwer, Devis Peressutti, Mark Gooding, Lisanne V. van Dijk, Paul Aljabar
Publikováno v:
Radiotherapy and Oncology, 142, 115-123. ELSEVIER IRELAND LTD
INTRODUCTION: Adequate head and neck (HN) organ-at-risk (OAR) delineation is crucial for HN radiotherapy and for investigating the relationships between radiation dose to OARs and radiation-induced side effects. The automatic contouring algorithms th
Autor:
Lisa Van den Bosch
Radiotherapy plays an important role in the treatment of head and neck cancer (HNC) patients. However, the tumour cannot be adequately radiated without irradiating healthy normal tissue as well. Irradiation of healthy tissues results in numerous toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20e3e23127635a4c0d9bf8b0a41f0a84
https://doi.org/10.33612/diss.218457157
https://doi.org/10.33612/diss.218457157
Autor:
Roel J H M Steenbakkers, Johannes A. Langendijk, Arjen van der Schaaf, Gyorgy B. Halmos, Tineke W.H. Meijer, Lisa Van den Bosch, E. Oldehinkel, Max J. H. Witjes, Johanna G M van den Hoek, Sjoukje F. Oosting, Hans Paul van der Laan
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, 111(2), 456-467. ELSEVIER SCIENCE INC
Purpose: Radiation therapy is an effective but burdensome treatment for head and neck cancer (HNC). We aimed to characterize the severity and time pattern of patient-reported symptoms and quality of life in a large cohort of patients with HNC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328e545e22645a0beacfc6a9bceab8cf
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629
https://research.rug.nl/en/publications/587e50dc-105e-44cc-b971-4fdaf8777629